Amylin: What might be its role in alzheimer's disease and how could this affect therapy?

Florin Despa, Charles Decarli

Producción científica: Review articlerevisión exhaustiva

24 Citas (Scopus)
Idioma originalEnglish
Páginas (desde-hasta)403-405
Número de páginas3
PublicaciónExpert Review of Proteomics
Volumen10
N.º5
DOI
EstadoPublished - 2013

Nota bibliográfica

Funding Information:
F Despa is supported by 1R01HL118474-01A1, NSF CBET-1133339, ADA 1-13-IN-70 and AHA 13GRNT16470034. C DeCarli is supported by NIA P30 AG10129. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Financiación

F Despa is supported by 1R01HL118474-01A1, NSF CBET-1133339, ADA 1-13-IN-70 and AHA 13GRNT16470034. C DeCarli is supported by NIA P30 AG10129. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

FinanciadoresNúmero del financiador
National Science Foundation (NSF)CBET-1133339, ADA 1-13-IN-70
National Institute on AgingP30 AG10129
National Heart, Lung, and Blood Institute (NHLBI)R01HL118474
American Historical Association 13GRNT16470034

    ASJC Scopus subject areas

    • Biochemistry
    • Molecular Biology

    Huella

    Profundice en los temas de investigación de 'Amylin: What might be its role in alzheimer's disease and how could this affect therapy?'. En conjunto forman una huella única.

    Citar esto